Slovenia CBD Market Regulatory Landscape Report 2021 - ResearchAndMarkets.com

·1 min read

DUBLIN, January 19, 2022--(BUSINESS WIRE)--The "CBD regulatory report: Slovenia" report has been added to ResearchAndMarkets.com's offering.

This report will provide you an overview of the current CBD regulatory landscape in Slovenia.

Slovenian law does not clearly distinguish between extracts from hemp and extracts from cannabis. It does not specifically address CBD or any other cannabinoids. CBD isolate from hemp may be prohibited other than medicinal or scientific use, apparently at odds with the Kanavape case. From 2017, cannabis has been allowed to be produced, marketed and possessed for medical purposes in Slovenia.

A bill setting out a proper procedure for obtaining a licence to cultivate medicinal cannabis is expected to be discussed soon in the parliament. Recreational cannabis is prohibited in Slovenia.

Key Topics Covered:

  1. Executive summary

  2. Outlook

  3. Hemp plant

  4. Extracts as finished products

  5. Finished products

  6. Import and export requirements

  7. Medical cannabis

  8. Recreational cannabis

  9. Relevant laws

  10. Relevant bodies

For more information about this report visit https://www.researchandmarkets.com/r/phenq7

View source version on businesswire.com: https://www.businesswire.com/news/home/20220119005530/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting